I am Jules Wendon from King's College Hospital in London.
I was talking today about the role of albumin.
Albumin seems to have a significant benefit in the management of patients with liver disease.
Essentially, there are different roles for albumin.
It has a role in liver disease, without question, particularly in the prevention of hepatorenal failure.
More interestingly, it also has marked inflammatory and anti-inflammatory capacity,
and I think increasingly we will see a role for albumin in sepsis,
where it seems to have a beneficial effect in terms of outcomes and mortality,
as shown in meta-analyses looking at immune function.